FDA: Page 86


  • Canada raises medical device regulatory fees

    The final fee schedule reflects a compromise after industry pushed back against higher rates initially proposed.

    By May 17, 2019
  • FDA classes J&J stapler recall as high risk ahead of advisory panel

    More than 92,000 of the devices made by the pharma's Ethicon unit are implicated in the U.S. recall.

    By May 17, 2019
  • Boston Scientific's Farapulse pulsed field ablation device. Explore the Trendline
    Image attribution tooltip
    Permission granted by Boston Scientific
    Image attribution tooltip
    Trendline

    New medical devices are reshaping the medtech industry

    From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.

    By MedTech Dive staff
  • FDA calls Essure postmarket study progress 'adequate' in adverse event update

    The agency said it received roughly 6,000 medical device reports related to the permanent birth control implant last year. Bayer halted U.S. sales at the end of 2018, but doctors can implant the device through the end of 2019.

    By Maria Rachal • May 16, 2019
  • Image attribution tooltip
    Adobe Stock
    Image attribution tooltip

    Physicians call for Digital Health Scorecard to validate products

    Following the models of consumer product evaluation organizations, doctors want transparent evaluations of new technologies.

    By May 16, 2019
  • Image attribution tooltip
    NOAA
    Image attribution tooltip

    B. Braun invests $1B in IV fluid manufacturing to alleviate shortages

    FDA's task force on drug shortages is expected to submit a report to Congress by year's end outlining potential solutions to address root causes of scarcities.

    By David Lim • May 15, 2019
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Medical equipment hit by escalation of US-China trade war

    Between tariffs already enacted and an additional $300 billion in products on the table, imaging equipment, diagnostic reagents, surgical gloves and contact lenses stand to be among the medical devices affected.

    By May 15, 2019
  • CMS will weigh broader mitral valve repair NCD, analysts predict

    Cowen analysts think Medicare's Coverage Analysis Group is likely to reconsider the national coverage determination for mitral valve repair in the second half of the year, which could benefit MitraClip maker Abbott.

    By May 14, 2019
  • Image attribution tooltip
    Jacob Bell
    Image attribution tooltip

    FDA extends Abiomed heart pump use to 14 days

    The new label more than doubles authorized length of use of the pumps and positions physicians to give critically ill patients longer to recover before deciding on next steps.

    By May 14, 2019
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    AliveCor snags FDA clearance for six-lead EKG

    Alongside an April clearance for its KardiaAI software to help identify bradycardia and tachycardia, the company is positioning itself to compete with the latest Apple Watch's electrocardiogram function.

    By David Lim • May 13, 2019
  • Medicare contractors finalize narrow coverage for glioblastoma treatment

    The local coverage determination for Novocure's tumor treatment field therapy will go into effect Sept. 1.

    By Updated July 19, 2019
  • Image attribution tooltip
    Flickr Creative Commons
    Image attribution tooltip

    Sen. Murray renews scrutiny of duodenoscope makers

    The top Democrat on the HELP committee is asking manufacturers Olympus, Fujifilm and Pentax how they plan to respond to FDA data showing what the senator calls "alarmingly high rates of contamination."

    By David Lim • Updated May 13, 2019
  • BD lowers guidance as FDA paclitaxel alert dents prospects

    The medtech expects sales of paclitaxel-coated balloons to fall 50% in the wake of FDA recommending against use of the devices.

    By May 9, 2019
  • FDA grants De Novo to device for cerebral aneurysms

    The temporary coil embolization assist device can deliver better outcomes than stents and balloon remodeling, Israeli manufacturer Rapid Medical says.

    By May 9, 2019
  • CMS pushes back 2021 DME bidding program window to July

    The Competitive Bidding Implementation Contractor released a 55-page guide and 18 additional fact sheets with instructions for the 2021 bidding round.

    By David Lim • May 8, 2019
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    FDA finalizes laser guidelines, rebuffing calls for harmonization

    The agency acknowledged the advantages of harmonization but will continue to enforce its own standards for now.

    By May 8, 2019
  • ACLA, AdvaMedDx, BIO call for VALID Act movement by year-end

    Despite differences between clinical labs and diagnostic manufacturers, industry wants to keep the legislation at the top of mind for Congress before the election and user fee negotiations suck oxygen away from the effort next year. 

    By David Lim • May 7, 2019
  • The FDA logo on a glass pane at the agency's campus in Silver Spring, Maryland.
    Image attribution tooltip
    Jacob Bell/MedTech Dive
    Image attribution tooltip

    FDA issues final guide on device submission meetings, feedback

    The agency also announced it will hold a webinar on June 11 to discuss the Q-Submission program.

    By May 7, 2019
  • Image attribution tooltip
    Kendall Davis/MedTech Dive
    Image attribution tooltip

    Touchstone Medical Imaging pays $3M to settle HIPAA breach case

    HHS found Touchstone failed to properly investigate the security incident until months after it learned of the breach.

    By May 7, 2019
  • EU issues device, diagnostics database requirements

    The documents detail what data manufacturers will need to include in the European Database on Medical Devices for devices and in vitro diagnostics under its new regulations.  

    By May 6, 2019
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Boston Scientific wins FDA approval for Vici stent

    The go-ahead creates competition for BD's Venovo stent, approved in March. Cook Medical and Medtronic are currently working to get their own versions to market.

    By David Lim • May 6, 2019
  • FDA seeks info on how patients view risks and benefits of devices

    One health policy analyst was skeptical of the initiative, pointing to what she characterized as industry recruitment of desperate patients willing to use insufficiently tested products.

    By Dana Elfin • May 3, 2019
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    FDA plan to limit old predicates not happening soon, 510(k) regulator says

    A decision to cut off use of old predicates at a specific age would "be awful," Marjorie Shulman, the assistant director of 510(k)s at FDA, said.

    By David Lim • May 3, 2019
  • FDA ends summary reporting, says it will not ban any breast implants

    The agency laid out plans to improve the accessibility of safety information about breast implants and also announced it will make public all prior adverse event reports related to the devices within a matter of weeks.

    By Maria Rachal • May 3, 2019
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    CMS to revamp coding for new medical technology

    Medical device companies will now be able to apply for a new permanent Healthcare Common Procedure Coding System code twice a year instead of annually. 

    By David Lim • May 3, 2019
  • Medtronic gets FDA approval for wireless pacemaker programmer

    The device is the follow-up to CareLink 2090, which has been dogged by cybersecurity weaknesses.

    By May 3, 2019